Abstract
Mutants of a catalytically inactive variant of Proteinase 3 (PR3)—iPR3-Val103 possessing a Ser195Ala mutation relative to wild-type PR3-Val103 —offer insights into how autoantigen PR3 interacts with antineutrophil cytoplasmic antibodies (ANCAs) in granulomatosis with polyangiitis (GPA) and whether such interactions can be interrupted. Here we report that iHm5-Val103, a triple mutant of iPR3-Val103, bound a monoclonal antibody (moANCA518) from a GPA patient on an epitope remote from the mutation sites, whereas the corresponding epitope of iPR3-Val103 was latent to moANCA518. Simulated B-factor analysis revealed that the binding of moANCA518 to iHm5-Val103 was due to increased main-chain flexibility of the latent epitope caused by remote mutations, suggesting rigidification of epitopes with therapeutics to alter pathogenic PR3·ANCA interactions as new GPA treatments.
Original language | English (US) |
---|---|
Article number | 2467 |
Journal | Frontiers in immunology |
Volume | 10 |
Issue number | OCT |
DOIs | |
State | Published - 2019 |
Keywords
- Antigenicity
- Antineutrophil cytoplasmic antibody
- Autoantigen
- Autoimmunity
- B-factor
- Proteinase 3
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology